Cell No. : Cell Name RCB5948 : LM8‐H/Lef1‐KO  update : 2023/12/01
Comment			Currently not ready.
Comment from the depositor			LM8-H cells with Lef-1 gene knockout using CRISPR-Cas9 system.
Terms and conditions
Remarks			CRISPR/Cas9 genome edited bioresources Announcement of bioresources developed by the CRISPR/Cas9 technology.
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
Reference information		Reference	1
		User's Publication	0

Top

Reference

17491  Pongsuchart M, Kuchimaru T, Yonezawa S, Tran DTP, Kha NT, Hoang NTH, Kadonosono T, Kizaka-Kondoh S.  Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs  Cancer Sci  2018  109(9):2746-2756  PubMed ID: 29927026   DOI: 10.1111/cas.13702

Top

User's Publication